Becton, Dickinson and Receives Consensus Recommendation of “Hold” from Analysts (NYSE:BDX)
Becton, Dickinson and (NYSE:BDX) has earned a consensus rating of “Hold” from the fifteen brokerages that are presently covering the stock, AnalystRatings.NET reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is $109.62.
Becton, Dickinson and (NYSE:BDX) opened at 119.67 on Friday. Becton, Dickinson and has a 52-week low of $96.73 and a 52-week high of $120.66. The stock’s 50-day moving average is $117.7 and its 200-day moving average is $113.6. The company has a market cap of $23.121 billion and a P/E ratio of 24.97.
Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings results on Thursday, May 1st. The company reported $1.45 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.50 by $0.05. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.09 billion. During the same quarter last year, the company posted $1.39 earnings per share. Becton, Dickinson and’s revenue was up 3.6% compared to the same quarter last year. On average, analysts predict that Becton, Dickinson and will post $6.25 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Monday, June 30th. Investors of record on Monday, June 9th will be given a dividend of $0.545 per share. This represents a $2.18 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, June 5th.
Several analysts have recently commented on the stock. Analysts at SunTrust raised their price target on shares of Becton, Dickinson and from $128.00 to $138.00 in a research note on Monday, June 9th. They now have a “buy” rating on the stock. Separately, analysts at RBC Capital raised their price target on shares of Becton, Dickinson and from $109.00 to $113.00 in a research note on Friday, May 9th. They now have a “sector perform” rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of Becton, Dickinson and from $108.00 to $110.00 in a research note on Friday, May 2nd.
Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.